UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacogenetic biomarkers: cytochrome P450 3A5

Clinica chimica acta, 2012-09, Vol.413 (17-18), p.1312-1317

MacPhee, Iain A.M.

2012

Volltextzugriff (PDF)

The Influence of Pharmacogenetics on the Time to Achieve Target Tacrolimus Concentrations after Kidney Transplantation

American journal of transplantation, 2004-06, Vol.4 (6), p.914-919

2004

Volltextzugriff (PDF)

Tacrolimus pharmacogenetics: the CYP3A51 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians

Transplantation, 2005-02, Vol.79 (4), p.499-502

2005

Volltextzugriff (PDF)

Estimated Glomerular Filtration Rate Correlates Poorly with Four-Hour Creatinine Clearance in Critically Ill Patients with Acute Kidney Injury

Critical Care Research and Practice, 2013-01, Vol.2013, p.406075-8

2013

Volltextzugriff (PDF)

Individualized immunosuppression in transplant patients: potential role of pharmacogenetics

Pharmacogenomics and personalized medicine, 2012-01, Vol.5 (default), p.63-72

2012

Volltextzugriff (PDF)

Handbook of Renal and Pancreatic Transplantation

1. Aufl., 2012

Volltextzugriff (PDF)

Measured Versus Estimated Glomerular Filtration Rate in the Assessment of Living Kidney Donors: eGFR Has Its Limitations

Transplantation, 2018-10, Vol.102 (10), p.1595-1596

MacPhee, Iain A.M.

2018

Volltextzugriff (PDF)

Renohepatic crosstalk: does acute kidney injury cause liver dysfunction?

Nephrology, dialysis, transplantation, 2013-07, Vol.28 (7), p.1634-1647

2013

Volltextzugriff (PDF)

Continuous Infusion of Low-Dose Iohexol Measures Changing Glomerular Filtration Rate in Critically Ill Patients

Critical care medicine, 2018-03, Vol.46 (3), p.e190-e197

2018

Volltextzugriff (PDF)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients

BMC nephrology, 2020-03, Vol.21 (1), p.92-92, Article 92

2020

Volltextzugriff (PDF)

A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipients

British journal of clinical pharmacology, 2013-09, Vol.76 (3), p.425-431

2013

Volltextzugriff (PDF)

A renal registry for Africa: first steps

Clinical kidney journal, 2016-02, Vol.9 (1), p.162-167

2016

Volltextzugriff (PDF)

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

Transplantation, 2002-12, Vol.74 (11), p.1486-1489

2002

Volltextzugriff (PDF)

CYP3A5 genotype had no impact on intrapatient variability of tacrolimus clearance in renal transplant recipients

Therapeutic drug monitoring, 2013-06, Vol.35 (3), p.328-331

2013

Volltextzugriff (PDF)

A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype

Transplantation, 2008-01, Vol.85 (2), p.163-165

2008

Volltextzugriff (PDF)

Using tramadol to measure CYP2D6 metabolism in critically ill adults

Intensive care medicine, 2014-08, Vol.40 (8), p.1177-1178

2014

Volltextzugriff (PDF)

Validation of a continuous infusion of low dose Iohexol to measure glomerular filtration rate: randomised clinical trial

Journal of translational medicine, 2015-02, Vol.13 (1), p.58-58, Article 58

2015

Volltextzugriff (PDF)

Use of pharmacogenetics to optimize immunosuppressive therapy

Therapeutic drug monitoring, 2010-06, Vol.32 (3), p.261-264

Macphee, Iain A M

2010

Volltextzugriff (PDF)

Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation

Therapeutic drug monitoring, 2011-04, Vol.33 (2), p.178-184

2011

Volltextzugriff (PDF)

Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements

Transplantation, 2006-09, Vol.82 (5), p.705-708

2006

Volltextzugriff (PDF)

Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groups

Nephrology, dialysis, transplantation, 2010-02, Vol.25 (2), p.628-634

2010

Volltextzugriff (PDF)

HSP70, Peroxiredoxin-3 and -6 are upregulated during renal warm ischaemia in a donation after circulatory death model

Journal of proteomics, 2014-08, Vol.108, p.133-145

2014

Volltextzugriff (PDF)

BK virus nephropathy in renal transplant patients in London

Transplantation, 2008-04, Vol.85 (7), p.1008-1015

2008

Volltextzugriff (PDF)

Using midazolam to monitor changes in hepatic drug metabolism in critically ill patients

Intensive care medicine, 2009-07, Vol.35 (7), p.1271-1275

2009

Volltextzugriff (PDF)

Tacrolimus dose in black renal transplant recipients

Transplantation, 2007-04, Vol.83 (7), p.997-999

2007

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(49)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacogenetic biomarkers: cytochrome P450 3A5

The Influence of Pharmacogenetics on the Time to Achieve Target Tacrolimus Concentrations after Kidney Transplantation

Tacrolimus pharmacogenetics: the CYP3A51 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians

Estimated Glomerular Filtration Rate Correlates Poorly with Four-Hour Creatinine Clearance in Critically Ill Patients with Acute Kidney Injury

Individualized immunosuppression in transplant patients: potential role of pharmacogenetics

Handbook of Renal and Pancreatic Transplantation

Measured Versus Estimated Glomerular Filtration Rate in the Assessment of Living Kidney Donors: eGFR Has Its Limitations

Renohepatic crosstalk: does acute kidney injury cause liver dysfunction?

Continuous Infusion of Low-Dose Iohexol Measures Changing Glomerular Filtration Rate in Critically Ill Patients

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients

A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipients

A renal registry for Africa: first steps

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

CYP3A5 genotype had no impact on intrapatient variability of tacrolimus clearance in renal transplant recipients

A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype

Using tramadol to measure CYP2D6 metabolism in critically ill adults

Validation of a continuous infusion of low dose Iohexol to measure glomerular filtration rate: randomised clinical trial

Use of pharmacogenetics to optimize immunosuppressive therapy

Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation

Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements

Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groups

HSP70, Peroxiredoxin-3 and -6 are upregulated during renal warm ischaemia in a donation after circulatory death model

BK virus nephropathy in renal transplant patients in London

Using midazolam to monitor changes in hepatic drug metabolism in critically ill patients

Tacrolimus dose in black renal transplant recipients

Suchergebnisse filtern